Fineline Cube

Follow:
14778 Articles
Chipscreen Biosciences' Tivozanib Secures NMPA Approval for ES-SCLC Phase III Trial
CompanyDrug

Shenzhen Chipscreen Biosciences’ Tivozanib Secures NMPA Approval for ES-SCLC Phase III Trial

Humanwell Healthcare Receives NMPA Approval for Compound Sodium Lactate Ringer's Injection
CompanyDrug

Humanwell Healthcare Receives NMPA Approval for Compound Sodium Lactate Ringer’s Injection

National Reimbursement Drug List (NRDL) Negotiations Conclude with Lower Generic Drug Approval Rate
Policy / Regulatory

National Reimbursement Drug List (NRDL) Negotiations Conclude with Lower Generic Drug Approval Rate

MSD Reports 4% YOY Revenue Increase in Q3 2024, Led by Pharmaceutical Sector
Company

MSD Reports 4% YOY Revenue Increase in Q3 2024, Led by Pharmaceutical Sector

Regeneron Pharmaceuticals Reports 11% YOY Revenue Growth in Q3 2024
Company

Regeneron Pharmaceuticals Reports 11% YOY Revenue Growth in Q3 2024

AbbVie Partners with EvolveImmune to Develop Immunotherapies for Cancer
CompanyDeals

AbbVie Partners with EvolveImmune to Develop Immunotherapies for Cancer

CARsgen Therapeutics' Suspended CAR-T Therapies Get FDA Green Light to Resume
CompanyDrug

CARsgen Therapeutics’ Suspended CAR-T Therapies Get FDA Green Light to Resume

AIM Vaccine Submits Market Filing for 13-Valent Pneumococcal Conjugate Vaccine in China
CompanyDrug

AIM Vaccine Submits Market Filing for 13-Valent Pneumococcal Conjugate Vaccine in China

Eisai and Biogen Complete BLA Submission for Alzheimer’s Drug Leqembi to FDA
CompanyDrug

Eisai and Biogen Complete BLA Submission for Alzheimer’s Drug Leqembi to FDA

Jenscare Scientific's LuX-Valve Plus Shows Positive One-Year Results in TRAVEL II Study
CompanyMedical Device

Jenscare Scientific’s LuX-Valve Plus Shows Positive One-Year Results in TRAVEL II Study

Biogen Reports Q3 2024 Sales Dip, Raises Full-Year Guidance
Company

Biogen Reports Q3 2024 Sales Dip, Raises Full-Year Guidance

Tasly Pharmaceuticals Gets FDA Approval for Acute Ischemic Stroke Cell Therapy Clinical Study
CompanyDrug

Tasly Pharmaceuticals Gets FDA Approval for Acute Ischemic Stroke Cell Therapy Clinical Study